Transcriptional regulation of the cyclin D1 gene at a glance
Author:
Affiliation:
1. Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Publisher
The Company of Biologists
Subject
Cell Biology
Link
http://journals.biologists.com/jcs/article-pdf/121/23/3853/1503449/3853.pdf
Reference80 articles.
1. Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A. and Pestell, R. G. (1995). Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem.270, 23589-23597.
2. Assoian, R. K. and Klein, E. A. (2008). Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol.18, 347-352.
3. Balmanno, K. and Cook, S. J. (1999). Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene18, 3085-3097.
4. Bartusel, T., Schubert, S. and Klempnauer, K.-H. (2005). Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites. Gene351, 171-180.
5. Beier, F., Lee, R. J., Taylor, A. C., Pestell, R. G. and LuValle, P. (1999). Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA96, 1433-1438.
Cited by 296 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09
2. Mitogen signaling strength and duration can control cell cycle decisions;Science Advances;2024-07-05
3. Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma;Acta Pharmaceutica Sinica B;2024-07
4. A Lifelike guided journey through the pathophysiology of pulmonary hypertension—from measured metabolites to the mechanism of action of drugs;Frontiers in Cardiovascular Medicine;2024-05-23
5. The MYC–NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells;Molecular Oncology;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3